IGF-1 lab test: what the number means
IGF-1 is not a direct measure of growth hormone — it’s a downstream signal that reflects how active the GH axis has been over the preceding days. Understanding the distinction matters when interpreting your result.
TL;DR
- IGF-1 (insulin-like growth factor 1) is produced primarily in the liver in response to GH signaling — it’s a surrogate marker, not GH itself.
- Reference ranges are tightly age- and sex-adjusted: a level that’s mid-range for a 30-year-old is elevated for a 60-year-old.
- Clinicians use IGF-1 to guide dosing decisions in GH-secretagogue protocols and to monitor for supraphysiological elevation.
What it is
IGF-1 is a peptide hormone produced primarily in the liver. It is released in response to growth hormone (GH) signaling from the pituitary and mediates many of GH’s downstream effects — including protein synthesis, cellular growth, and metabolic regulation. Because GH itself has a pulsatile secretion pattern (levels fluctuate significantly hour-to-hour), a random serum GH measurement is not clinically useful. IGF-1 has a longer half-life and more stable serum concentration, making it a reliable integrated measure of recent GH-axis activity. The Endocrine Society uses serum IGF-1 as the primary biochemical tool for both diagnosing adult GH deficiency and monitoring GH-axis therapy (Endocrine Society, 2019).
How it works
IGF-1 levels are reported in ng/mL and are compared against age- and sex-specific reference ranges derived from large population studies. LabCorp and Quest Diagnostics publish laboratory-specific reference intervals; clinicians use the range corresponding to the patient’s age and sex at the time of the draw. The chart below shows the general shape of the IGF-1 age-decline curve across a male lifespan, based on published population norms.
Who asks about it
People who’ve received their IGF-1 result from a standard lab draw often have two questions: is this number high or low, and what does it mean for their protocol? The answer to both requires knowing the age-adjusted reference range, which most lab reports include but many patients don’t know how to read.
What the research says
Elevated IGF-1 — specifically levels sustained above the age-adjusted upper limit of normal — is associated with the condition of acromegaly when caused by a GH-secreting pituitary tumor. Physiological elevation from a GH-secretagogue protocol does not carry the same pathological implications, but clinicians monitor IGF-1 precisely to ensure levels do not exceed the normal range for age (Katznelson et al., Endocrine Society Clinical Practice Guideline for Acromegaly, 2014). Age-specific normal ranges for IGF-1 are published by both LabCorp and Quest Diagnostics and are the reference used in clinical interpretation.
What to know before considering it
IGF-1 interpretation requires clinical context: the same number can be appropriate or concerning depending on your age, sex, baseline, and current protocol. A number at the top of the normal range may prompt a prescriber to adjust dosing; a number modestly below the lower limit may confirm the rationale for a GH-secretagogue protocol. Neither interpretation is something to reach for without a clinician’s guidance.
The Halftime POV
The IGF-1 test is one of the more informative single biomarkers in a preventive health panel — it provides a window into GH-axis function that most standard annual physicals don’t include. For patients on protocols that affect the GH axis, having a documented baseline and consistent follow-up cadence is what separates a well-managed protocol from a poorly monitored one.
Related reading:
FAQ
Q: What does an IGF-1 lab test measure? A: IGF-1 (insulin-like growth factor 1) is produced primarily by the liver in response to growth hormone signaling. Because GH itself has a short half-life and is released in pulses, IGF-1 is used as a more stable, measurable proxy for GH-axis activity. A single blood draw for IGF-1 reflects GH activity over the preceding days rather than at a single moment.
Q: What are normal IGF-1 reference ranges? A: IGF-1 reference ranges are age-adjusted — they vary significantly across the lifespan. Peak values are typically in early adulthood (approximately 180–300 ng/mL for adults in their 20s, depending on the lab). Values decline with age: clinicians typically compare a patient’s IGF-1 to the reference range for their specific age group, not a single universal range.
Q: What does a low IGF-1 mean? A: Low IGF-1 relative to age-adjusted reference ranges may indicate reduced GH-axis activity — one component of somatopause. It can also reflect nutritional status, liver function, or hypothyroidism, which is why a complete metabolic context is important before attributing low IGF-1 solely to GH decline. The interpretation requires a clinician’s assessment of the full lab picture.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
Sources
- Yuen KCJ et al., “American Association of Clinical Endocrinologists Guidelines for Management of Growth Hormone Deficiency in Adults” — Endocrine Practice, 2019
- Katznelson L et al., “Acromegaly: An Endocrine Society Clinical Practice Guideline” — JCEM, 2014
- IGF-1 Reference Intervals — LabCorp Test Menu
